Section Arrow
Quote
MYGN.NASDAQ
- Myriad Genetics
Quotes are at least 15-min delayed:2026/03/30 09:17 EDT
Regular Hours
Last
 --
-- (--)
Day High 
-- 
Prev. Close
4.28 
1-M High
5.485 
Volume 
-- 
Bid
4.29
Ask
5.05
Day Low
-- 
Open
-- 
1-M Low
4.27 
Market Cap 
398.95M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.62 
20-SMA 4.83 
50-SMA 5.03 
52-W High 9.02 
52-W Low 3.76 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.95/0.05
Enterprise Value
601.85M
Balance Sheet
Book Value Per Share
3.94
Cash Flow
Cash Flow Yield
0.00
Income Statement
Total Revenue
824.50M
Operating Revenue Per Share
7.88
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
XWELXWELL-------- 
XGNExagen-------- 
WGSGeneDx Holdings Corp------801.91PE
WATWaters Corp------26.95PE
VCYTVeracyte------36.6PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.